Objectives: In 2006 the rotavirus vaccine was included in the Brazilian Immunization Program. The aim of this study was to report the results of a 5-year surveillance study of rotavirus strains in children < 5 years with acute gastroenteritis from day care centers in the state of São Paulo, Brazil. 
Introduction
Viral pathogens are the most common causes of gastroenteritis in communities and other settings, including semi-closed institutions and hospitals. 1 In infancy, group A rotavirus (RVA) are considered to be the most important etiological agent of acute non-bacterial gastroenteritis, including outbreaks and sporadic cases, independent of improvements in basic sanitation and hygiene procedures. 2 RVA are the major etiologic agent of acute diarrhea in children, responsible for more than 600,000 deaths each year, 3 in addition to the significant economic burden of RVA disease. 4 In 2006 an attenuated G1P [8] vaccine was included in the Brazilian Immunization Program, preventing severe rotavirus gastroenteritis, and inducing significant reduction in the frequency of RVA detection in children with gastroenteritis. 5 In fact, the RIX4414 vaccine efficacy was evaluated by Araujo Rotavirus molecular characterization in day care centers -Morillo SG et al.
et al., 6 showing 53.9 to 81.5% of protection against severe cases, and 81.2 to 93.0% of protection against hospitalization due to rotavirus gastroenteritis in children.
Recently, a high prevalence of G2P [4] was reported in Brazil and linked with this vaccination, 7 suggesting that this monovalent vaccine possibly created conditions in which G2P [4] could acquire selective advantage over P [8] genotypes. More detailed investigations concerning the heterological protection conferred by rotavirus monovalent vaccine are key points to understand its immunogenic behavior. 6, 8 The aim of this study was to report the results of a 5-year surveillance study of rotavirus strains in children < 5 years with acute gastroenteritis from day care center in the state of São Paulo, Brazil, and to evaluate detection trends.
Methods
This 
Discussion
Our data show the presence of RVA G9P [8] , G2P [4] , and G1P [8] in agreement with the reported worldwide prevalence of these three genotypes. 9 As expected, G9 was the most The G2P [4] genotype was the only strain observed during 2007. Alternatively to the proposition that the RIX4414 vaccine created conditions in which G2P [4] could have acquired selective advantage, a temporal periodicity, within ~ 10-year cyclic pattern of G2P [4] has been observed in Brazil, 11 
